Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2014

View Archived Issues

hAT-MSCs partially restore corneal epithelial phenotype in an in vivo model of LSCD

Temozolomide causes biological and radiological improvements in pituitary carcinoma case study

Sanofi creates hybrid VEGF/PDGF soluble receptors for AMD

Novel bispecific antibody for the treatment of P. aeruginosa infection

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

Discovery of a unique bacterial zinc metalloprotease inhibitor

Beraprost sodium single isomer shows potential for influenza

KinoPharma and Carna Biosciences patent new DYRK1A inhibitors

Researchers at Zafgen design novel MetAP 2 inhibitors for obesity

Allergan reports discovery of S1P1 receptor ligands

Bristol-Myers Squibb and CytomX Therapeutics establish immune-oncology collaboration

BioCryst reports preliminary results from OPuS-1 study of BCX-4161 for HAE

Spark Therapeutics completes Series B financing

Novogen identifies compounds active against prostate cancer cells

Roche licenses rights to antibody engineering technologies from Chugai

MacroGenics and Takeda Pharmaceutical enter into option agreement for MGD-010

RaQualia Pharma researchers prepare and test Na channel blockers

U.S. investigators report development of HDAC inhibitors for AKI

TetraLogic selects phase II dose of birinapant for higher risk MDS

BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer

Enrollment under way in phase I study of MEDI-7510 for RSV

European approval for Entyvio in ulcerative colitis and Crohn's disease

Xarelto filed in Japan for three indications

Valeant makes revised proposal to Allergan, plans to sell filler and toxin assets to Nestle

FDA grants fast track designation to obeticholic acid for primary biliary cirrhosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...